Antibodies to a human integrin alpha/beta heterodimeric protein
AssigneeThe Scripps Research Institute
InventorsVito Quaranta, Richard N. Tamura
Life of this patent
Estimating the term…
Abstract
Novel hybridoma cell lines producing monoclonal antibodies which react specifically with human pancreatic cancer cells are described. Methods for producing antigenic preparations to generate the hybridoma cell lines and for selecting, purifying and characterizing the monoclonal antibodies reactive with human cells, including pancreatic cancer cells, are disclosed. The antigens to which the antibodies of the invention are specific are characterized.
Claims3
An antibody that immunoreacts with an isolated human heterodimeric protein complex of 400 kd by SDS PAGE or 500 kd by gel filtration, wherein said complex immunoreacts with the monoclonal antibody having ATCC accession number HB 9318, and wherein said complex consists essentially of:
- a) a first glycopeptide characterized by having an apparent molecular weight in SDS-PAGE under reducing conditions of 205 kd and under non-reducing conditions of 190 kd, and glycosidase susceptibility to treatment with endo F and neuraminidase but not endo H;
- and
- b) a second glycopeptide characterized by having an apparent molecular weight in SDS-PAGE under reducing conditions of 125 kd and under non-reducing conditions of 150 kd, and susceptibility to treatment with glycosidases selected from the group consisting of endo F, endo H and neuraminidase, said second glycopeptide including the N-terminal amino acid residue sequence F-N-L-D-T-R-E-D-N-V-I-R-K-Y-G-D-P-G-S-L-F.
Dependencies are inferred from the claim text.